Inventor · disambiguated record

Kunwar Shailubhai

Also filed as: SHAILUBHAI KUNWAR

50 granted patents·47 pending applications·692 citations·filing 2002–2025

99Inventor score

Technology areasA61P A61K C07K B01D C12N

Files withSYNERGY PHARMACEUTICALS INC43 BAUSCH HEALTH IRELAND LTD27 TIZIANA LIFE SCIENCES PLC15 SHAILUBHAI KUNWAR7 BAI JUNCAI1

Top patents by PatentIndex Score

97 records

0198US7879802B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2008·Granted Feb 1, 2011·47 cites·6 claims
0297US8969514B2Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseasesSHAILUBHAI KUNWAR·Filed 2009·Granted Mar 3, 2015·25 cites·11 claims
0397US8716224B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSHAILUBHAI KUNWAR·Filed 2011·Granted May 6, 2014·31 cites·5 claims
0497US8637451B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSHAILUBHAI KUNWAR·Filed 2011·Granted Jan 28, 2014·27 cites·3 claims
0597US8367800B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2011·Granted Feb 5, 2013·40 cites·3 claims
0697US8357775B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2012·Granted Jan 22, 2013·37 cites·4 claims
0797US8114831B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSHAILUBHAI KUNWAR·Filed 2010·Granted Feb 14, 2012·37 cites·4 claims
0897US8034782B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2009·Granted Oct 11, 2011·42 cites·3 claims
0997US7799897B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSYNERGY PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·44 cites·4 claims
1097US7041786B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSYNERGY PHARMACEUTICALS INC·Filed 2002·Granted May 9, 2006·102 cites·6 claims
1196US11319346B2Ultra-pure agonists of guanylate cyclase C, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2021·Granted May 3, 2022·3 cites·12 claims
1296US9089612B2Method of inhibiting bile acid absorption by administering an agonist of a guanylate cyclase receptorSHAILUBHAI KUNWAR·Filed 2010·Granted Jul 28, 2015·21 cites·3 claims
1396US8569246B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2012·Granted Oct 29, 2013·25 cites·3 claims
1496US8497348B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2012·Granted Jul 30, 2013·28 cites·4 claims
1596US8207295B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSHAILUBHAI KUNWAR·Filed 2009·Granted Jun 26, 2012·32 cites·3 claims
1695US11142549B2Ultra-pure agonists of guanylate cyclase C, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2020·Granted Oct 12, 2021·3 cites·6 claims
1795US9266926B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·14 cites·6 claims
1895US9238677B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jan 19, 2016·14 cites·12 claims
1995US8901075B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2013·Granted Dec 2, 2014·16 cites·6 claims
2095US8664354B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2013·Granted Mar 4, 2014·17 cites·3 claims
2194US11834521B2Ultra-pure agonists of guanylate cyclase C, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2023·Granted Dec 5, 2023·1 cites·17 claims
2294US10688186B2Anti-CD3 antibody formulationsTIZIANA LIFE SCIENCES PLC·Filed 2017·Granted Jun 23, 2020·7 cites·33 claims
2393US10745441B2Ultra-pure agonists of guanylate cyclase C, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2018·Granted Aug 18, 2020·5 cites·12 claims
2492US9814752B2Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseasesSYNERGY PHARMACEUTICALS INC·Filed 2015·Granted Nov 14, 2017·4 cites·11 claims
2592US9505805B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2015·Granted Nov 29, 2016·7 cites·12 claims
2691US10011637B2Ultra-pure agonists of guanylate cyclase C, method of making and using sameSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jul 3, 2018·8 cites·24 claims
2791US9914752B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·5 cites·11 claims
2890US2025171497A1Ultra-pure agonists of guanylate cyclase c, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2024·Application pending·0 cites
2988US12146003B2Ultra-pure agonists of guanylate cyclase C, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2023·Granted Nov 19, 2024·0 cites·12 claims
3088US9610321B2Formulations of guanylate cyclase C agonists and methods of useSYNERGY PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·4 cites·16 claims
3187US9920095B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2015·Granted Mar 20, 2018·5 cites·12 claims
3287US9486494B2Compositions useful for the treatment of gastrointestinal disordersSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Nov 8, 2016·7 cites·16 claims
3387US2024002440A1Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersBAUSCH HEALTH IRELAND LTD·Filed 2023·Application pending·0 cites
3485US9708367B2Agonists of guanylate cyclase and their usesSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jul 18, 2017·5 cites·7 claims
3584US10421787B2Process of preparing guanylate cyclase C agonisysBAUSCH HEALTH IRELAND LTD·Filed 2017·Granted Sep 24, 2019·3 cites·8 claims
3684US10232011B2Formulations of guanylate cyclase C agonists and methods of useSYNERGY PHARMACEUTICALS INC·Filed 2018·Granted Mar 19, 2019·2 cites·19 claims
3783US9545446B2Agonists of guanylate cyclase and their usesSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·6 cites·13 claims
3882US10973773B2Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemiaTIZIANA LIFE SCIENCES PLC·Filed 2017·Granted Apr 13, 2021·1 cites·5 claims
3981US10238712B2Compositions useful for the treatment of gastrointestinal disordersSYNERGY PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·2 cites·14 claims
4079US10597424B2Agonists of guanylate cyclase and their usesBAUSCH HEALTH IRELAND LTD·Filed 2018·Granted Mar 24, 2020·1 cites·9 claims
4179US2024285632A1Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancerTIZIANA LIFE SCIENCES PLC·Filed 2023·Application pending·0 cites
4278US9616097B2Formulations of guanylate cyclase C agonists and methods of useCOMISKEY STEPHEN·Filed 2012·Granted Apr 11, 2017·6 cites·12 claims
4378US9580471B2Process of preparing guanylate cyclase C agonistsBAI JUNCAI·Filed 2012·Granted Feb 28, 2017·4 cites·12 claims
4478US2022119449A1Ultra-pure agonists of guanylate cyclase c, method of making and using sameBAUSCH HEALTH IRELAND LTD·Filed 2021·Application pending·0 cites
4577US10118946B2Agonists of guanylate cyclase and their usesSYNERGY PHARMACEUTICALS INC·Filed 2017·Granted Nov 6, 2018·1 cites·11 claims
4677US10034836B2Formulations of guanylate cyclase C agonists and methods of useSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jul 31, 2018·2 cites·6 claims
4776US2021205406A1Formulations of guanylate cyclase c agonists and methods of useBAUSCH HEALTH IRELAND LTD·Filed 2021·Application pending·0 cites
4875US2020283480A1Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersBAUSCH HEALTH IRELAND LTD·Filed 2020·Application pending·0 cites
4974US2020384068A1Formulations of guanylate cyclase c agonists and methods of useBAUSCH HEALTH IRELAND LTD·Filed 2020·Application pending·0 cites
5073US10967043B2Agonists of guanylate cyclase and their usesBAUSCH HEALTH IRELAND LTD·Filed 2019·Granted Apr 6, 2021·0 cites·8 claims

Showing the top 50 of 97 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Kunwar Shailubhai files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →